N-terminally extended form of human hemopressin that acts as a selective CB1
receptor agonist. Increases intracellular Ca2+
levels in cells expressing CB1
receptors in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Novel endogenous peptide agonists of cannabinoid receptors.
Gomes et al.
FASEB J., 2009;23:3020